Cargando…
Phosphorothioate modified oligonucleotide–protein interactions
Antisense oligonucleotides (ASOs) interact with target RNAs via hybridization to modulate gene expression through different mechanisms. ASO therapeutics are chemically modified and include phosphorothioate (PS) backbone modifications and different ribose and base modifications to improve pharmacolog...
Autores principales: | Crooke, Stanley T, Vickers, Timothy A, Liang, Xue-hai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7261153/ https://www.ncbi.nlm.nih.gov/pubmed/32356888 http://dx.doi.org/10.1093/nar/gkaa299 |
Ejemplares similares
-
NAT10 and DDX21 Proteins Interact with RNase H1 and Affect the Performance of Phosphorothioate Oligonucleotides
por: Zhang, Lingdi, et al.
Publicado: (2022) -
Binding of phosphorothioate oligonucleotides with RNase H1 can cause conformational changes in the protein and alter the interactions of RNase H1 with other proteins
por: Zhang, Lingdi, et al.
Publicado: (2021) -
The delivery of therapeutic oligonucleotides
por: Juliano, Rudolph L.
Publicado: (2016) -
Identification and characterization of intracellular proteins that bind oligonucleotides with phosphorothioate linkages
por: Liang, Xue-hai, et al.
Publicado: (2015) -
Cellular uptake mediated by epidermal growth factor receptor facilitates the intracellular activity of phosphorothioate-modified antisense oligonucleotides
por: Wang, Shiyu, et al.
Publicado: (2018)